← FDA DRUG APPROVALS

FDA ANDA · ANDA204857

LACOSAMIDE

Sponsor: AMNEAL PHARMS

APPLICATION
ANDA204857
TYPE
ANDA
ORIGINAL APPROVAL
2022-03-17
LATEST ACTION
2022-03-17
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

LACOSAMIDEDiscontinued
LACOSAMIDE 200MG · TABLET · ORAL
LACOSAMIDEDiscontinued
LACOSAMIDE 100MG · TABLET · ORAL
LACOSAMIDEDiscontinued
LACOSAMIDE 150MG · TABLET · ORAL
LACOSAMIDEDiscontinued
LACOSAMIDE 50MG · TABLET · ORAL

Approval history

2022-03-17UNKNOWN · Original · standard — Medication Guide ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →